Interferon-beta is a current treatment for multiple sclerosis (MS). Interferon-beta is thought to exert its therapeutic effects on MS by down-modulating the immune response by multiple potential pathways. Here, we document that treatment of MS patients with interferon beta-1a (Rebif) results in a si...
Détails bibliographiques
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 133(2009), 1 vom: 17. Okt., Seite 27-44
|
|---|
| Auteur principal: |
Christophi, George P
(Auteur) |
|---|
| Autres auteurs: |
Panos, Michael,
Hudson, Chad A,
Tsikkou, Chriso,
Mihai, Cornelia,
Mejico, Luis J,
Jubelt, Burk,
Massa, Paul T |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2009
|
|---|
| Accès à la collection: | Clinical immunology (Orlando, Fla.)
|
|---|
| Sujets: | Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Cytokines
NF-kappa B
RNA, Small Interfering
STAT1 Transcription Factor
STAT1 protein, human
STAT6 Transcription Factor
STAT6 protein, human
plus...
Interferon-beta
77238-31-4
Protein Tyrosine Phosphatase, Non-Receptor Type 6
EC 3.1.3.48
Interferon beta-1a
XRO4566Q4R |
|---|